Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation

• Principais autores: Lori Regenstreif (Autor), Marina Sadik (Autor), Erin Beaulieu (Autor), Claire Bodkin (Autor), Lori Kiefer (Autor), Dale Guenter (Autor), Patsy W. P. Lee (Autor), Fiona G. Kouyoumdjian (Autor)
• Formato: Livro
• Publicado em: BMC, 2022-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract People with opioid use disorders are overrepresented in correctional facilities, and are at high risk of opioid overdose. Despite the fact that buprenorphine/naloxone is the first line treatment for people with opioid use disorder, there are often institutional, clinical, and logistical bar...